Oriola Oyj operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oriola Oyj with three other
drug stores in Europe:
sales of 7.08 billion Polish New Zlotys [US$2.06 billion]
of which 99%
was Pharmaceutical Wholesale),
Udg Healthcare Plc
(943.08 million Euro [US$1.14 billion]
of which 62%
was Ashfield), and
Selcuk Ecza Deposu Ticaret ve Sanayi AS
based in Turkey
(8.64 billion Turkish Liras [US$2.30 billion]
of which 100%
was Medical and Hospital Equipment).
During the year ended December of 2016, sales at
Oriola Oyj were 1.64 billion Euro (US$1.99 billion).
a very small
increase of 1.0%
versus 2015, when the company's sales were 1.63 billion Euro.